Skip to main content
. 2024 Mar 15;15:1342545. doi: 10.3389/fneur.2024.1342545

Table 2.

Basic features of included studies.

Included studies Number M/F Average age Course of disease Outcomes
(T/C) T C T C T C
Megna et al. (37) 15/15 8:7 7:8 58.9 ± 5.4 59.3 ± 6.2 - - (1) (4) (8) (9) (10)
Santamato et al. (38) 16/16 7:9 6:10 64.4 ± 6.09 63.1 ± 7.03 10.5 ± 2.12(m) 9.3 ± 3.97(m) (1) (4) (7)
Lu (41) 39/39 26:13 26:13 59.04 ± 4.43 58.95 ± 4.38 14.82±2.72(d) 14.74±2.67(d) (1) (2) (4) (6)
Liang et al. (40) 30/30 17:13 16:14 49.93 ± 11.23 50.09 ± 11.07 60.07±11.13 (d) 50.09±11.07(d) (1) (2) (3)
Duan et al. (39) 18/18 8:10 9:9 51.8 ± 6.2 52.6 ± 7.9 90.5±19.4(d) 87.5±18.7(d) (1) (2) (3) (5)
Wang et al. (42) 20/20 9:11 11:9a 52.18 ± 13.66 51.23±14.24a 7.61±3.50(m) 7.98±3.05(m)a (1) (2) (3)
12:8b 50.89±15.16b 8.02±3.17(m)b

T is the treatment group; C is the control group; “-” indicates no report; (1) MAS score; (2) FMA score; (3) MBI score; (4) VAS score; (5) PROM; (6) BBS rating; (7) SFS score; (8) muscle tone; (9) Muscle stiffness; (10) Adverse reactions. Wang et al. included two control groups, aindicates the conventional rehabilitation group, bindicates conventional rehabilitation combined with BTX-A; d = day; m = mouth.